A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels
Blood Glucose
Male
population
Polymorphism, Single Nucleotide
Body Mass Index
regulatory protein
03 medical and health sciences
Meta-Analysis as Topic
Insulin-Secreting Cells
Insulin Secretion
Humans
Insulin
Genetic Predisposition to Disease
Alleles
disease
locus
0303 health sciences
Fasting
Introns
Diabetes Mellitus, Type 2
genome-wide association
Glucose-6-Phosphatase
Linear Models
mortality risk
Female
diabetes-mellitus
DOI:
10.1126/science.1156849
Publication Date:
2008-05-04T04:48:51Z
AUTHORS (23)
ABSTRACT
Several studies have shown that healthy individuals with fasting plasma glucose (FPG) levels at the high end of the normal range have an increased risk of mortality. To identify genetic determinants that contribute to interindividual variation in FPG, we tested 392,935 single-nucleotide polymorphisms (SNPs) in 654 normoglycemic participants for association with FPG, and we replicated the most strongly associated SNP (rs560887,
P
= 4 × 10
–7
) in 9353 participants. SNP rs560887 maps to intron 3 of the
G6PC2
gene, which encodes glucose-6-phosphatase catalytic subunit–related protein (also known as IGRP), a protein selectively expressed in pancreatic islets. This SNP was associated with FPG (linear regression coefficient β = –0.06 millimoles per liter per A allele, combined
P
= 4 × 10
–23
) and with pancreatic β cell function (Homa-B model, combined
P
= 3 × 10
–13
) in three populations; however, it was not associated with type 2 diabetes risk. We speculate that
G6PC2
regulates FPG by modulating the set point for glucose-stimulated insulin secretion in pancreatic β cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (197)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....